NU

Nassim Usman

President & Chief Executive Officer at Totus Medicines

South San Francisco, California

Overview

Work Experience

TM

Totus Medicines

  • President & Chief Executive Officer

    2023 - Current

Morgenthaler Ventures

  • Entrepreneur in Residence & Venture Partner

    2005

Gyre Therapeutics

  • Member Board of Directors

    2023 - 2024

CB

Catalyst Biosciences

  • President & CEO, Member Board of Directors

    2006 - 2023

MB

Mosaic Biosciences

  • Member Board Of Directors

    2011 - 2020

PB

Principia Biopharma

  • Member Board Of Directors

    2011 - 2018

Sirna Therapeutics

  • COO & CSO

    2003 - 2005

Atugen AG

  • Member Of The Supervisory Board

    1999 - 2003

Ribozyme Pharmaceuticals

  • VP R&D & CSO

    1992 - 2003

MI

Massachusetts Institute of Technology (MIT)

  • Postdoctoral Fellow, Staff Scientist

    1987 - 1992

Education

Investments

Principia Biopharma

Series A

Total Funding: $78M

Catalyst Biosciences

Post Ipo Equity

Total Funding: $88M

Relevant Websites